New York-based investment firm I Squared Capital has pressed the start button on the long-awaited multibillion euro sale of ...

Viridian Therapeutics stock popped Monday after ... This beat out the 8% response rate in the placebo group and was in line with expectations for a 52% to 62% response rate, RBC Capital Markets ...

WALTHAM, Mass., March 10, 2025--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and ...

"Over the past year we worked a lot with the Roux Institute, and it still feels like we're based there," said Jeff Joyce, who chairs Viridian's intellectual property group from Portland.

AlphaQuest LLC increased its stake in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 119.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 2,795 shares of ...